About Hitachi General Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hitachi General Hospital
During the past decade, Hitachi General Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
1996-11-01
2010-12-01
Completed
77
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1998-10-01
2016-12-01
Completed
682
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
1999-05-01
2012-08-01
Completed
19,747
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
1999-10-15
2018-05-01
Completed
983
4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer
1997-08-01
2014-12-01
Terminated
521
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hitachi General Hospital"
#1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hitachi General Hospital
According to Clinical.Site data, the most researched conditions in "Hitachi General Hospital" are
"Myelodysplastic Syndromes" (2 trials), "Colitis, Ulcerative" (1 trials), "Crohn's Disease" (1 trials), "Crohns Disease" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Hitachi General Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Hitachi General Hospital
Most popular intervention types in "Hitachi General Hospital" are "Drug" (8 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bortezomib" (2 trials), "Dexamethasone" (2 trials), "Guselkumab" (2 trials), "Luspatercept" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hitachi General Hospital
The vast majority of trials in "Hitachi General Hospital" are
8 trials for "All" genders.
Clinical Trials Status at Hitachi General Hospital
Currently, there are NaN active trials in "Hitachi General Hospital".
undefined are not yet recruiting,
4 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Hitachi General Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hitachi General Hospital, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".